Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Environmental Contaminants Infiltrate Placenta during Pregnancy

By HospiMedica International staff writers
Posted on 14 Feb 2019
Researchers at Karolinska Institutet (KI; Solna, Sweden), Rigshospitalet (Copenhagen, Denmark), and Copenhagen University (Denmark) conducted a study to measure the concentrations of distinct PFAS in human embryos and fetuses and corresponding placentas and maternal serum samples derived from elective pregnancy terminations and intrauterine fetal death cases. More...
In all, 78 embryos and fetuses aged 7–42 gestational weeks were included for a total of 225 fetal organs, together with 71 placentas and 63 maternal serum samples. PFAS concentrations were assayed by liquid chromatography/triple quadrupole mass spectrometry.

The results revealed that PFAS concentrations in embryo/fetal tissue were lower than maternal serum, but similar to placenta concentrations. The total PFAS burden was highest in lung tissue in first trimester samples and in the liver in second and third trimester samples. The burden was lowest in CNS samples, irrespective of fetal age. The researchers found that placenta:maternal serum ratios increased across gestation, suggesting bioaccumulation in the placenta, and that the ratios were higher in pregnancies with male fetuses. The study was published on January 24, 2019, in Environment International.

“The main source of PFAS substances today is food, in the form of fish, milk, meat, and eggs, or in the drinking water, if you happen to live in a polluted area,” said senior author Pauliina Damdimopoulou, PhD, of the KI department of clinical science, intervention and technology. “We ingest them as a cocktail of substances that can also interact with each other. It would be in line with the precautionary principle in the restriction of chemical substances to make sure that all PFAS substances disappear from our society.”

The PFAS group comprises thousands of human-made chemicals with alkyl chains in which fluoride atoms replace hydrogen atoms, forming strong carbon fluorine bonds resistant to degradation. Thanks to their water- and grease-resistant properties, they are used in everything from frying pans and food packaging to clothes, cleaning agents, and firefighting foams. Many PFAS are regulated due to their bioaccumulative properties and toxicity for reproduction, and one, perfluorooctanesulfonic acid (PFOS) was banned by the European Union in 2008.

Related Links:
Karolinska Institutet
Rigshospitalet
Copenhagen University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.